| Name: | Citalopram EP Impurity D |
| Catalogue No. | VL920007 |
| CAS No. | 62498-67-3 |
| Molecular Formula | C19H20BrFN2O |
| Molecular Weight | 391.28 g/mol |
| Status | In-stock |
| IUPAC Name | 1-(4-Fluorophenyl)-1-(3-methylamino-propyl)-1,3-dihydro-isobenzofuran-5-carbonitrile Hydrobromide |
| Synonyms | EsCitalopram EP Impurity D/ Citalopram Related Compound D/ N-Desmethyl Citalopram (HBr salt) |
| Appearance | Off white solid |
| Description | Citalopram EP Impurity D (CAS No: 62498-67-3) or Desmethyl Citalopram / Citalopram Related Compound D is a metabolite of Citalopram and is detected in breast milk and serum of mother and infant. Citalopram is a selective serotonin reuptake inhibitor (SSRI) and it is a well-tolerated and effective SSRI antidepressant. |
| References | “Citalopram and Desmethylcitalopram Concentrations in Breast ... : Therapeutic Drug Monitoring.” LWW, 2021, journals.lww.com/drug-monitoring/Abstract/1997/04000/Citalopram_and_Desmethylcitalopram_Concentrations.21.aspx. Bezchlibnyk-Butler, K., et al. “Citalopram--a Review of Pharmacological and Clinical Effects.” Journal of Psychiatry & Neuroscience : JPN, vol. 25, no. 3, 2000, pp. 241–54, www.ncbi.nlm.nih.gov/pmc/articles/PMC1407724/ |
